Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.
Severe damage to the blood-brain barrier (BBB) allows anti-aquaporin 4 (AQP4) antibodies to access the astrocytic endfeet in neuromyelitis optica (NMO). In the current study, we identified the pathogenic cytokines/chemokines that are responsible for the BBB malfunction induced by NMO sera.We measure...
Main Authors: | Fumitaka Shimizu, Hideaki Nishihara, Yasuteru Sano, Yukio Takeshita, Shiori Takahashi, Toshihiko Maeda, Toshiyuki Takahashi, Masaaki Abe, Michiaki Koga, Takashi Kanda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4374747?pdf=render |
Similar Items
-
GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica
by: Fumitaka Shimizu, et al.
Published: (2019-10-01) -
Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
by: Hideaki Nishihara, et al.
Published: (2015-01-01) -
Neuromyelitis optica
by: Jacob Anu, et al.
Published: (2007-01-01) -
Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4–Positive Neuromyelitis optica Spectrum Disorder
by: Tetsuya Akaishi, et al.
Published: (2021-02-01) -
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
by: Fumitaka Shimizu, et al.
Published: (2014-01-01)